Cargando…
Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study
BACKGROUND: Progestin-only contraceptive pills (POP) are commonly reserved for women with medical comorbidities but in actuality, POPs can be safely used by anyone wanting to prevent pregnancy. This wide safety profile makes them an ideal candidate for being available over the counter without a pres...
Autores principales: | Edelman, Alison, Hemon, Agnes, Creinin, Mitchell, Borensztein, Pascale, Scherrer, Bruno, Glasier, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262664/ https://www.ncbi.nlm.nih.gov/pubmed/33970869 http://dx.doi.org/10.2196/29208 |
Ejemplares similares
-
Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021) -
Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021) -
Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023) -
Interest in Continued Use After Participation in a Study of Over-the-Counter Progestin-Only Pills in the United States
por: Grindlay, Kate, et al.
Publicado: (2022) -
The efficacy, acceptability and continuation of postpartum, post-abortive progestin-only pill: a pioneering prospective multicentric study from Turkey
por: Dilbaz, Berna, et al.
Publicado: (2022)